Tatva Chintan Pharma Chem Management
Management Kriterienprüfungen 3/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Chintan Shah
Geschäftsführender
₹13.4m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 25.0% |
| Amtszeit als Geschäftsführer | 28.3yrs |
| Eigentum des Geschäftsführers | 23.8% |
| Durchschnittliche Amtszeit des Managements | keine Daten |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 15.9yrs |
Jüngste Management Updates
Recent updates
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues
Sep 26
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00
Aug 29Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%
Jul 27Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)
May 11Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts
Jan 26Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year
May 10Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next
Jul 28Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely
Jun 17Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings
May 03Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?
Dec 06Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹261m |
| Mar 31 2024 | ₹13m | ₹3m | ₹304m |
| Dec 31 2023 | n/a | n/a | ₹377m |
| Sep 30 2023 | n/a | n/a | ₹459m |
| Jun 30 2023 | n/a | n/a | ₹452m |
| Mar 31 2023 | ₹17m | ₹5m | ₹455m |
| Dec 31 2022 | n/a | n/a | ₹460m |
| Sep 30 2022 | n/a | n/a | ₹572m |
| Jun 30 2022 | n/a | n/a | ₹825m |
| Mar 31 2022 | ₹17m | ₹5m | ₹959m |
| Dec 31 2021 | n/a | n/a | ₹995m |
| Sep 30 2021 | n/a | n/a | ₹976m |
| Jun 30 2021 | n/a | n/a | ₹687m |
| Mar 31 2021 | ₹14m | n/a | ₹523m |
| Mar 31 2020 | ₹14m | n/a | ₹378m |
| Mar 31 2019 | ₹14m | n/a | ₹205m |
Vergütung im Vergleich zum Markt: ChintanDie Gesamtvergütung ($USD160.11K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Indian ($USD179.25K).
Entschädigung vs. Einkommen: ChintanDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Chintan Shah (51 yo)
28.3yrs
Amtszeit
₹13,390,870
Vergütung
Mr. Chintan Nitinkumar Shah is the Managing Director and Chairman at Tatva Chintan Pharma Chem Limited and its Executive Director since June 12, 1996. He holds a bachelor’s degree in engineering, with a sp...
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chairman & MD | 28.3yrs | ₹13.39m | 23.84% ₹ 5.9b | |
| Whole Time Director | 28.3yrs | ₹13.39m | 24.01% ₹ 5.9b | |
| Whole Time Director | 28.3yrs | ₹13.39m | 24% ₹ 5.9b | |
| Non Executive Independent Director | 3.6yrs | ₹265.00k | keine Daten | |
| Non Executive Independent Director | 3.6yrs | ₹285.00k | keine Daten | |
| Non Executive Independent Director | 3.6yrs | ₹22.50k | keine Daten |
15.9yrs
Durchschnittliche Betriebszugehörigkeit
51.5yo
Durchschnittliches Alter
Erfahrener Vorstand: TATVADie Vorstandsmitglieder sind sehr erfahren ( 15.7 ).